-
Tipo NewsRICERCA PARTNER
-
FonteSIMPLER
-
Del
A Greek research team intends to submit a proposal to the MSCA-ITN-2016-ETN call (deadline 12/01/2016), in order to establish an ITN network to train PhDs on basic and pre-clinical research relating to the development of chemical compounds that regulate adaptive immune responses as possible therapeutics for cancer & autoimmunity. The consortium already includes partners from Greece, France, UK, Spain, Israel & Italy. They are looking for relevant industrial partners to join the consortium.
- Type and Role of Partner Sought: Industry & SME interested in the pre-clinical development of novel compounds for cancer immunotherapy or the regulation of autoimmune responses. In particular, industrial partners working in the fields of:
- Organic synthesis / scale up
- Computational modelling of drug-protein interactions / drug design
- X-ray crystallography
- Pharmacokinetics / pharmacodynamics analysis
- Experimental animal models for cancer and autoimmunity
- Proteomics
- Cellular models for preclinical drug evaluation
- Toxicity evaluation
Per ulteriori informazioni finalizzate ad attivare una partnership, segnaliamo che è possibile:
- scrivere all'indirizzo e-mail [email protected], se localizzati nella regione Emilia-Romagna
- individuare l'ente di riferimento per la propria regione sul sito ufficiale di Enterprise Europe Network, se localizzati in altre regioni d'Italia riportando, in ogni caso, il codice: RDGR20151020002